Q: What is Jevtana used for?

Jevtana is used to treat prostate cancer .

Q: How does Jevtana work?

Mechanism of Action Jevtana belongs to a group of medicines called taxanes. It works by targeting the internal framework of cells, specifically structures known as microtubules. Microtubules are essential for cell division. In a healthy cycle, these structures constantly assemble and disassemble to help the cell split into two. Jevtana binds to these microtubules and prevents them from breaking down. This stabilization freezes the cell's internal machinery, making it impossible for the cell to complete the division process. Because cancer cells divide much more rapidly than most normal cells, they are particularly sensitive to this interference. By preventing cell division, Jevtana helps to: Slow the growth of the tumor. Stop the spread of cancer cells to other parts of the body. Induce cell death in the targeted cancer cells.

Q: What are the active ingredients in Jevtana?

The active ingredient in Jevtana is cabazitaxel .

Q: What are the side effects of Jevtana?

Common side effects of Jevtana may include: Neutropenia Diarrhea Fatigue and others. Always consult with a healthcare professional about potential side effects.

Q: What drug class is Jevtana?

Jevtana belongs to the taxane chemotherapy agent drug class.

Q: What is the dosage of Jevtana and how do I take it?

Administration Jevtana is given as an injection into a vein (intravenous infusion) by a healthcare professional in a medical setting, such as a hospital or clinic. The infusion process generally takes about one hour. Treatment Schedule This medication is usually administered once every three weeks. Your healthcare provider will determine the total number of treatment cycles based on your response to the medication and your overall health. Combination Therapy Jevtana is typically used in combination with an oral corticosteroid, such as prednisone. You will likely be instructed to take the oral medication every day throughout your treatment period. It is important to follow your doctor's instructions regarding the timing of the oral medication. Premedication To reduce the risk of allergic reactions or certain side effects, your healthcare provider will give you other medications before each infusion. These may include antihistamines, corticosteroids, or medications to prevent nausea. These are typically administered at least 30 minutes before the Jevtana infusion starts. Missed Doses Because Jevtana is administered by a healthcare professional, it is important to keep all scheduled appointments. If you miss an appointment for your infusion, contact your doctor immediately to reschedule. If you miss a dose of the oral medication prescribed to be taken at home, contact your healthcare provider for instructions on when to take the next dose.

Q: Is Jevtana safe during pregnancy and breastfeeding?

Pregnancy Risks Jevtana is not indicated for use in women. Based on its mechanism of action and findings from animal studies, this medication can cause significant harm to a developing fetus if exposure occurs during pregnancy. Contraception for Men Because Jevtana can affect sperm and potentially cause birth defects, male patients with female partners who are able to become pregnant should follow these precautions: Use effective contraception (birth control) during treatment. Continue using effective contraception for 3 months after the final dose of Jevtana. Breastfeeding It is not known whether Jevtana passes into human breast milk. Due to the potential for serious adverse reactions in a nursing infant, breastfeeding is not recommended during treatment with this medication. Fertility Animal studies suggest that Jevtana may impair male fertility. Men who are concerned about their ability to father a child in the future should discuss these risks and potential options with their healthcare provider before starting treatment.

Q: What is the FDA approval status of Jevtana?

FDA Approval and Indications The U.S. Food and Drug Administration (FDA) approved Jevtana in June 2010. It is indicated for use in combination with prednisone to treat patients with metastatic castration-resistant prostate cancer who were previously treated with a docetaxel-containing regimen. In 2017, the FDA approved a lower dose (20 mg/m 2 every three weeks) to provide an alternative for patients who may not tolerate the standard dose of 25 mg/m 2 . Boxed Warnings Jevtana includes a boxed warning regarding several serious safety risks: Neutropenia: This condition involves a severe drop in white blood cell counts, which can lead to life-threatening infections. Deaths related to infection have been reported. Patients must have frequent blood count monitoring during treatment. Hypersensitivity Reactions: Severe allergic reactions can occur, including low blood pressure and respiratory distress. Patients are usually given antihistamines and corticosteroids before treatment to minimize this risk. Gastrointestinal Complications: Severe diarrhea, dehydration, and gastrointestinal hemorrhage or perforation have occurred, some of which were fatal. Jevtana is also contraindicated in patients with severe hepatic impairment or those with low baseline neutrophil counts. Regulatory Status and Generics Generic versions of cabazitaxel are FDA-approved and available. The medication is administered as an intravenous infusion by healthcare professionals in a clinical setting. There are no Risk Evaluation and Mitigation Strategy (REMS) programs currently required for this drug, but it must be administered under the supervision of a physician experienced in the use of cancer chemotherapeutic agents.

Question 1

What is Jevtana?

Accepted Answer

Jevtana is a type of chemotherapy drug known as a microtubule inhibitor or taxane. It belongs to a broader class of medicines called antineoplastics, which are designed to destroy cancer cells.

The medication works by disrupting the internal structure of cells, which prevents them from dividing and growing. By targeting these cellular processes, it helps slow or stop the progression of cancer within the body.

Question 2

What is Jevtana used for?

Accepted Answer

Jevtana is used to treat prostate cancer.

Question 3

How does Jevtana work?

Accepted Answer

Mechanism of Action

Jevtana belongs to a group of medicines called taxanes. It works by targeting the internal framework of cells, specifically structures known as microtubules.

Microtubules are essential for cell division. In a healthy cycle, these structures constantly assemble and disassemble to help the cell split into two. Jevtana binds to these microtubules and prevents them from breaking down. This stabilization freezes the cell's internal machinery, making it impossible for the cell to complete the division process.

Because cancer cells divide much more rapidly than most normal cells, they are particularly sensitive to this interference. By preventing cell division, Jevtana helps to:

Slow the growth of the tumor.
Stop the spread of cancer cells to other parts of the body.
Induce cell death in the targeted cancer cells.

Question 4

What are the active ingredients in Jevtana?

Accepted Answer

The active ingredient in Jevtana is cabazitaxel.

Question 5

What are the side effects of Jevtana?

Accepted Answer

Common side effects of Jevtana may include:

Neutropenia
Diarrhea
Fatigue
and others.

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Jevtana?

Accepted Answer

Jevtana belongs to the taxane chemotherapy agent drug class.

Question 7

What is the dosage of Jevtana and how do I take it?

Accepted Answer

Administration

Jevtana is given as an injection into a vein (intravenous infusion) by a healthcare professional in a medical setting, such as a hospital or clinic. The infusion process generally takes about one hour.

Treatment Schedule

This medication is usually administered once every three weeks. Your healthcare provider will determine the total number of treatment cycles based on your response to the medication and your overall health.

Combination Therapy

Jevtana is typically used in combination with an oral corticosteroid, such as prednisone. You will likely be instructed to take the oral medication every day throughout your treatment period. It is important to follow your doctor's instructions regarding the timing of the oral medication.

Premedication

To reduce the risk of allergic reactions or certain side effects, your healthcare provider will give you other medications before each infusion. These may include antihistamines, corticosteroids, or medications to prevent nausea. These are typically administered at least 30 minutes before the Jevtana infusion starts.

Missed Doses

Because Jevtana is administered by a healthcare professional, it is important to keep all scheduled appointments. If you miss an appointment for your infusion, contact your doctor immediately to reschedule. If you miss a dose of the oral medication prescribed to be taken at home, contact your healthcare provider for instructions on when to take the next dose.

Question 8

Is Jevtana safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy Risks

Jevtana is not indicated for use in women. Based on its mechanism of action and findings from animal studies, this medication can cause significant harm to a developing fetus if exposure occurs during pregnancy.

Contraception for Men

Because Jevtana can affect sperm and potentially cause birth defects, male patients with female partners who are able to become pregnant should follow these precautions:

Use effective contraception (birth control) during treatment.
Continue using effective contraception for 3 months after the final dose of Jevtana.

Breastfeeding

It is not known whether Jevtana passes into human breast milk. Due to the potential for serious adverse reactions in a nursing infant, breastfeeding is not recommended during treatment with this medication.

Fertility

Animal studies suggest that Jevtana may impair male fertility. Men who are concerned about their ability to father a child in the future should discuss these risks and potential options with their healthcare provider before starting treatment.

Question 9

What forms and strengths does Jevtana come in?

Accepted Answer

Jevtana is supplied as a kit for injection. This kit typically includes:

A single-dose vial containing the active medication as a concentrated solution.
A separate vial containing a diluent used to prepare the medication for administration.

The medication must be mixed and diluted by a healthcare provider before use. It is administered as an intravenous (IV) infusion, which means it is delivered directly into a vein.

Question 10

What is the FDA approval status of Jevtana?

Accepted Answer

FDA Approval and Indications

The U.S. Food and Drug Administration (FDA) approved Jevtana in June 2010. It is indicated for use in combination with prednisone to treat patients with metastatic castration-resistant prostate cancer who were previously treated with a docetaxel-containing regimen. In 2017, the FDA approved a lower dose (20 mg/m 2 every three weeks) to provide an alternative for patients who may not tolerate the standard dose of 25 mg/m 2 .

Boxed Warnings

Jevtana includes a boxed warning regarding several serious safety risks:

Neutropenia: This condition involves a severe drop in white blood cell counts, which can lead to life-threatening infections. Deaths related to infection have been reported. Patients must have frequent blood count monitoring during treatment.
Hypersensitivity Reactions: Severe allergic reactions can occur, including low blood pressure and respiratory distress. Patients are usually given antihistamines and corticosteroids before treatment to minimize this risk.
Gastrointestinal Complications: Severe diarrhea, dehydration, and gastrointestinal hemorrhage or perforation have occurred, some of which were fatal.

Jevtana is also contraindicated in patients with severe hepatic impairment or those with low baseline neutrophil counts.

Regulatory Status and Generics

Generic versions of cabazitaxel are FDA-approved and available. The medication is administered as an intravenous infusion by healthcare professionals in a clinical setting. There are no Risk Evaluation and Mitigation Strategy (REMS) programs currently required for this drug, but it must be administered under the supervision of a physician experienced in the use of cancer chemotherapeutic agents.

Question 11

What should I know about Jevtana and cost?

Accepted Answer

Cost and Coverage

The total cost of Jevtana treatment depends on several factors, including the setting where the medication is administered and the patient's insurance coverage. Because Jevtana is an intravenous injection given by a healthcare professional, it is usually covered under the medical benefit portion of insurance plans rather than a pharmacy benefit. For patients with Medicare, it is typically covered under Medicare Part B.

Generic Options

Generic versions of cabazitaxel are available. Generic medications typically cost less than brand-name drugs. Patients should consult their healthcare provider or insurance company to see if a generic version is a suitable and more affordable option for their treatment plan.

Financial Assistance

Financial assistance programs may be available through the drug manufacturer or third-party organizations to help reduce out-of-pocket costs for eligible patients. These programs often include co-pay cards or patient assistance for those who are uninsured or underinsured. Patients are encouraged to speak with a financial counselor at their treatment facility to explore these options.

Jevtana

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Jevtana

Hospitals.net Disclosure